



BONE MARROW METABOLISM IS IMPAIRED IN INSULIN RESISTANCE AND 
































BONE MARROW METABOLISM IS IMPAIRED IN INSULIN RESISTANCE AND 


























Kevätlukukausi 2021  
Vastuuhenkilö: Jarna Hannukainen 
The originality of this thesis has been checked in accordance with the University of 






OJALA, RONJA: Bone Marrow Metabolism Is Impaired in Insulin Resistance 
and Improves After Exercise Training 
 





Bone marrow (BM) insulin sensitivity has been suggested to play an important role in 
bone health and whole-body insulin sensitivity. Exercise training improves bone 
mineral density, but little is known about the effects of training on BM metabolism. We 
studied the effects of sprint interval training (SIT) and moderate-intensity continuous 
training (MICT) on BM metabolism.  
 
54 sedentary subjects (healthy n=28, insulin resistant (IR) n=26, aged=40-55) were 
randomized into two weeks of SIT or MICT. Femoral, lumbar and thoracic BM insulin-
stimulated glucose uptake (GU) and fasting free fatty acid uptake (FFAU) were 
measured using positron-emission tomography. Bone turnover markers osteocalcin and 
procollagen type 1 N-terminal propeptide (PINP) were measured from plasma. 
 
At baseline, GU was highest in lumbar, followed by thoracic and lowest in femoral BM. 
FFAU was higher in lumbar and thoracic than in femoral BM. Femoral BM GU was 
higher in healthy compared to IR men and in females compared to males. BM FFAU 
was higher in healthy compared to IR men and higher in females than males. Exercise 
increased femoral BM GU similarly in all groups and decreased lumbar BM FFAU in 
men. Osteocalcin and PINP were lower in IR than healthy men and correlated positively 
with femoral BM GU and glycemic status. 
 
BM substrate uptake differs regarding anatomical location and is impaired in insulin 
resistance. Short-term exercise training improves BM metabolism in healthy and IR 
subjects. Bone turnover rate is decreased in insulin resistance and associates positively 
with BM metabolism and glycemic control.  
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Context: Exercise training improves bone mineral density, but little is known about the 
effects of training on bone marrow (BM) metabolism. BM insulin sensitivity has been 
suggested to play an important role in bone health and whole-body insulin sensitivity. 
Objective: To study the effects of exercise training on BM metabolism. 
Design: Randomized controlled trial 
Setting: Clinical research center 
Participants: Sedentary healthy (n=28, 40-55 years, all males) and insulin resistant 
subjects (IR) (n=26, 43-55 years, males/females 16/10) 
Intervention: Two weeks of sprint interval training or moderate-intensity continuous 
training 
Main outcome measures: We measured femoral, lumbar and thoracic BM insulin-
stimulated glucose uptake (GU) and fasting free fatty acid uptake (FFAU) using 
positron-emission tomography and bone turnover markers from plasma. 
Results: At baseline, GU was highest in lumbar, followed by thoracic and lowest in 
femoral BM (all p<0.0001). FFAU was higher in lumbar and thoracic than femoral BM 
(both p<0.0001). BM FFAU and femoral BM GU were higher in healthy compared to 
IR men and in females compared to males (all p<0.05). Training increased femoral BM 
GU similarly in all groups and decreased lumbar BM FFAU in males (all p<0.05). 
Osteocalcin and PINP were lower in IR than healthy men and correlated positively with 
femoral BM GU and glycemic status (all p<0.05). 
Conclusions: BM metabolism differs regarding anatomical location. Short-term training 
improves BM GU and FFAU in healthy and IR subjects. Bone turnover rate is 
decreased in insulin resistance and associates positively with BM metabolism and 





Bone marrow is the porous tissue found within all bones of the body. Bone marrow 
consists of hematopoietic cells (blood cells and their precursors), other stem cells, 
adipose tissue and trabecular bone. The ratio of these components differs according to 
anatomical location. When a child is born, almost all their bone cavities are filled with 
hematopoietic bone marrow tissue. During aging hematopoietic bone marrow is slowly 
replaced by adipose tissue from the periphery towards the axial skeleton (1). In adults, 
hematopoietic bone marrow can still be found in the axial skeleton and in the proximal 
ends of long bones, such as femur and humerus (2). Thus, one important function of 
bone marrow in the axial skeleton is the production of blood cells while the bone cavity 
of long bones serves as a specialized fat depot. However, despite the known differences 
in bone marrow it is unclear whether the metabolism differs between anatomical 
locations. 
Bone marrow cavity is the only place in the human body where bone and fat tissue are 
directly connected without any membrane between the two tissues (3). It is not known 
whether bone marrow metabolism affects bone turnover and homeostasis. For example, 
bone marrow insulin resistance may be a potential factor for impaired bone health. Most 
studies have found increased risk of bone fractures in type 2 diabetic patients, despite 
normal or increased bone mineral density (4–6). It has been suggested that increased 
bone marrow adipose tissue volume is associated with increased fracture risk (7,8). 
Using magnetic resonance spectroscopy, Schellinger et al found an inverse relationship 
between bone marrow adipose tissue volume and bone integrity (9). Furthermore, the 
volume of bone marrow adipose tissue correlates negatively with hematopoietic activity 
of bone marrow (10). 
It is known that exercise training improves whole-body insulin sensitivity. To our 
knowledge, only Huovinen et al. have studied the effects of exercise training on bone 
marrow insulin sensitivity. It was shown that four months of resistance training 
increased femoral bone marrow insulin sensitivity in elderly female subjects (11). 
However, it is not known whether bone marrow metabolism is impaired in insulin 
resistance and whether exercise training can improve it. 
We set out to investigate the short-term effects of two training methods, sprint interval 
training (SIT) and moderate-intensity continuous training (MICT), on glucose and free 
fatty acid metabolism of bone marrow in healthy and insulin resistant subjects using 2-
[18F]fluoro-2-deoxy-D-glucose (18F-FDG) and 14(R,S)-[18F]fluoro-6-thia-heptadecanoic 
acid (18F-FTHA) PET imaging. The aims of our study were to investigate bone marrow 
insulin-stimulated glucose uptake (GU) and fasting free fatty acid uptake (FFAU) 
(A) at baseline between 
a. healthy and insulin-resistant men and 
b.insulin-resistant men and women. 
(B) after a two-week training intervention between 
a. healthy and insulin-resistant men, 
b. insulin-resistant men and women, and 
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c. between SIT and MICT training modes. 
In addition to PET imaging, bone turnover markers were measured from plasma. We 
hypothesized that glucose and fatty acid uptake would be highest in the lumbar vertebral 
region due to hematopoiesis, impaired in insulin resistance, and lower in males 
compared to females. We further hypothesized that exercise training would effectively 
enhance bone marrow metabolism, with SIT being superior to MICT.  
METHODS 
Ethics 
This study was part of a larger study entitled “The effects of short-time high-intensity 
interval training on tissue glucose and fat metabolism in healthy subjects and in patients 
with type 2 diabetes” (NCT01344928). Basic outcomes included in this article have 
already been published for some of the study population (whole-body insulin 
sensitivity, aerobic fitness, and basic characteristics) (12–15). No data considering 
metabolism of bone marrow has previously been published from this study. The study 
was conducted at Turku PET Centre (University of Turku, Turku, Finland), Turku 
University Hospital (Turku, Finland) and the Paavo Nurmi Centre (Turku, Finland) 
between March 2011 and September 2015 in compliance with the Declaration of 
Helsinki. The study protocol was approved by the ethical committee of the Hospital 
District of Southwest Finland (decision 95/180/2010 §228). Before any measurements 
were performed the purpose and potential risks of the study were explained and written 
consent was obtained. 
Subjects 
Middle-aged, sedentary, healthy subjects and subjects with insulin resistance (IR) were 
recruited for the study via newspaper advertisements, personal contacts, and traditional 
and electronic bulletin boards. The inclusion criteria for healthy subjects (n=28, aged 
40-55 years, all male) were as previously published by Honkala et al (12). 
Inclusion criteria for IR subjects (n = 26, aged 43-55 years, male/female = 16/10) were 
as previously published (14). Of the 26 IR subjects 17 (11 men) met the criteria for type 
2 diabetes mellitus (T2DM) and nine (five men) met the criteria for prediabetes having 
impaired fasting glucose concentrations and/or impaired glucose tolerance as defined by 
American Diabetes Association guidelines (16). Of the 17 subjects with T2DM, 13 were 
treated with at least one type of oral hypoglycemic medication. The median diabetes 
duration was 4.2 years. Four subjects (one man) met the criteria for T2DM at screening 
and had no previous medication. In addition, seven IR subjects were taking statins. In 
total, seven subjects dropped out during the intervention, one due to exercise-induced 
hip pain, one due to training induced migraine, one due to claustrophobic feeling within 
the MRI scanner, and four due to personal reasons (Figure 1A). All participants were 
asked not to change their habitual dietary intake during the study period. 
Study design 
Study design is shown in Figure 1B. Initial screening consisted of a physical 
examination, an oral glucose tolerance test (OGTT), and a VO2peak test to assess the 
participant’s glycemic status and aerobic capacity. At least 1 week after the screening 
day 18F-FTHA-PET study was performed to measure FFAU in thoracic vertebral, 
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lumbar vertebral and femoral bone marrow. The following day, 18F-FDG-PET study 
was performed during euglycemic-hyperinsulinemic clamp to measure whole body 
insulin sensitivity (M-value) and GU in bone marrow in the same anatomical regions. 
Visceral fat was measured with MRI as previously described by Motiani et al (17). 
Subjects were asked to avoid exhausting exercise, caffeinated and alcoholic beverages 
and stop all antidiabetic medications 48 hours prior to any measurements. 
After the pre-training measurements the subjects were randomized into two training 
groups for the two-week exercise intervention, sprint interval training (SIT) and 
moderate-intensity continuous training (MICT), as previously described (12). The final 
group sizes for healthy subjects were n=14 for SIT and n=14 for MICT, and for IR 
subjects n=13 for SIT and n=13 for MICT. 
After the training intervention, all measurements were repeated starting ~48 hours after 
the last training session. 18F-FTHA-PET study was performed first. The following day, 
~72 hours after the last training session, 18F-FDG-PET study was performed. Finally, 
OGTT and VO2peak test were repeated after ~96 hours after the last training session. 
Exercise intervention 
The intervention was carried out as previously described by Honkala et al (12). Both 
training groups had six supervised training sessions within two weeks in controlled 
laboratory conditions. Given the nature of the intervention, no blinding was used. The 
SIT sessions consisted of 4-6 maximal all-out cycling bouts (Monark Ergomedic 894E; 
MONARK, Vnasbro, Sweden) of 30 s with a 4-minute recovery period in between 
(Wingate protocol). During the recovery period, the subjects could either remain still or 
do unloaded cycling. The amount of cycling bouts started at 4 and was increased by 1 
bout after every other training session. The study subjects were familiarized with the 
SIT protocol ~1 week before the intervention by doing two 30-second bouts. The MICT 
sessions consisted of 40-60 min of cycling at a moderate intensity with a load of 60% of 
their individual VO2peak intensity (Tunturi E85; Tunturi Fitness, Almere, Netherlands). 
The cycling time started at 40 minutes and was increased by 10 minutes every other 
training session until 60 minutes was reached. 
PET measurements and euglycemic-hyperinsulinemic clamp 
The PET/CT images were acquired using GE Discovery TM ST System (General 
Electric Medical Systems, Milwaukee, WI, USA). CT images were acquired for 
anatomical reference and radiodensity extraction. The participants fasted for ≥ 10 hours 
before the PET studies. To arterialize venous blood for the length of the study, an 
electrically powered heating cushion was placed under the arm where the blood samples 
were taken from.  
Bone marrow free fatty acid uptake was measured using 18F-FTHA in a fasting state. 
Lumbar (vertebrae Th12-L3), femoral (middle of the thigh), and thoracic regions 
(vertebrae Th1-Th4) were then scanned starting at ~46, ~65 and ~86 minutes after tracer 
injection (156 [SEM 1.1] MBq), respectively.  
Glucose uptake was measured using 18F-FDG during euglycemic-hyperinsulinemic 
clamp. The clamp was performed as previously published by Defronzo et al (18). 
Whole-body insulin-stimulated glucose uptake (M-value) was calculated from the 
glucose infusion rate as described earlier (17). The 18F-FDG-PET study (157 [SEM 
9 
 
0.9] MBq) started 91 min (SE 2) after the start of the clamp and lumbar vertebral, 
femoral and thoracic vertebral regions were scanned starting ~47, ~67 and ~93 minutes 
after tracer injection, respectively. In the IR group thoracic region was not scanned. 
Image analysis 
The imaging data obtained from the PET scanner was corrected for dead-time, decay, 
and photon attenuation. The 3D-OSEM method was used to reconstruct the images. 
Carimas 2.9 software (http://turkupetcentre.fi) was used to manually draw three-
dimensional regions of interest (ROIs) in the marrow cavities of femurs and thoracic 
and lumbar vertebrae. CT images were used as anatomical reference. The ROIs were 
carefully drawn to only include the marrow cavity and to leave out cortical bone and 
surrounding tissue. An example of the shape and positioning of the ROIs can be seen in 
Figure 2. From these ROIs time activity curves were extracted. 
The radiodensity of tissue is expressed in Hounsfield Units (HU), obtained from a linear 
transformation of attenuation coefficients based on the arbitrary definitions of air 
(−1000 HU) and water (0 HU). On this scale, fat has a density of -60 to -120 HU (19). 
In bone marrow, the amount of fat cannot be quantified, but the lower the HU, the 
higher the fat content. For radiodensity analysis, regions of interest (ROIs) were drawn 
onto the CT images. In the thigh area, a ROI covering the entire mid-shaft of the femur 
was drawn. The CT voxels within this ROI were then thresholded to separate cortical 
bone from the bone marrow tissue. The HU threshold level for differentiating cortical 
bone from bone marrow tissue was considered to be 400 HU based on visual evaluation 
as well as previously documented HU range of cortical bone and bone marrow (20). In 
lumbar area, ROIs were drawn onto the CT images carefully avoiding cortical bone as 
in PET ROIs. No thresholding was necessary, as only trabecular bone area was 
included. 
Other measurements: VO2peak test, OGTT and bioimpedance analysis 
Aerobic capacity was determined by performing an incremental VO2peak bicycle 
ergometer test as previously described by Kiviniemi et al (21). A 2-hour, 75-g OGTT 
was done after the subjects had fasted for at least 12 hours. After ingestion of glucose, 
blood samples were collected at 0, 15, 30, 60, 90 and 120 minutes to determine glucose 
and insulin concentrations in the blood. Body composition was measured with a 
bioimpedance monitor (InBody 720, Mega Electronics, Kuopio, Finland). 
Bone turnover markers 
Blood samples were collected in the mornings of the 18F-FTHA-PET studies after an 
overnight fast and EDTA plasma samples were stored as aliquots at – 80 °C. Bone 
formation was assessed by measuring intact N-terminal propeptides of type I collagen 
(PINP) (22) by using IDS-iSYS Intact PINP assay (IDS Ltd, UK). Bone-specific 
osteocalcin, a marker of bone remodeling, was measured with two-site immunoassay 
using a previously described protocol (23). Assay detects total osteocalcin and is based 




Sample size was calculated for the whole study based on its primary outcome (skeletal 
muscle glucose uptake) (13). No sample size calculation was performed on the outcome 
measures of this study. 
The normal distribution of the variables was tested using Shapiro-Wilk test and 
evaluated visually. Logarithmic (log10) transformations were performed to fulfill the 
normal distribution assumption (whole-body insulin sensitivity (M-value), lumbar bone 
marrow free fatty acid uptake, osteocalcin (for comparisons in insulin resistant group), 
PINP). Statistical analyses were performed using hierarchical mixed linear models with 
compound symmetry covariance structure. First, the differences between healthy and IR 
men were studied with the model, which included one within-factor term (time; 
indicating the overall mean change between baseline and measurement after the 
intervention), two between-factor terms (glycemic status: healthy and IR men; training: 
SIT and MICT) and two interaction terms (time × glycemic status: indicating whether 
mean change during the study was different between healthy and IR men; time × 
training: indicating whether mean change during the study was different between SIT 
and MICT). IR women were only included in comparisons within the IR group to avoid 
mixing the effects of sex and glucose intolerance. Second, differences between SIT and 
MICT in IR participants, including both men and women, were studied using a model 
that included within-factor time (time; indicating the overall mean change between 
baseline and measurement after the intervention), two between-factor terms (training: 
SIT and MICT; sex: male and female) and two interaction term (time × sex: indicating 
whether mean change during the study was different between IR men and IR women; 
time × training: indicating whether mean change during the study was different between 
SIT and MICT). The analyses were carried out using the intention-to-treat principle and 
included all the randomized participants. Due to the chosen analysis method, also 
participants with missing data could be included into statistical modelling. Furthermore, 
model-based means (SAS least square means) and 95% confidence intervals (CI) are 
reported for all the parameters. Correlations were calculated using Pearson’s correlation 
(Spearman’s rank correlation for non-normally distributed data). 
To study which variables affect the GU and FFAU of bone marrow we used the 
multivariate regression analysis, which is a technique that estimates a single regression 
model with multiple outcome variables and one or more predictor variables. 
The statistical tests were performed as two-sided and the level of statistical significance 
was set at 0.05. The analyses were performed using SAS System, version 9.4 for 
Windows (SAS Institute, Cary, NC, USA).  
RESULTS 
Before intervention, IR men had impaired aerobic capacity (p <0.001) compared to 
healthy men, but training improved aerobic capacity similarly in both groups (time p = 
0.003, time*IR p = 0.23) (Table 1). When divided by training mode, only SIT improved 
aerobic capacity in IR subjects with no differences between men and women (data not 
shown). IR men had significantly lower whole-body insulin sensitivity (M-value) at 
baseline (p <0.001), but it improved after training with no differences between the 
groups or training modes (time p <0.001) (Table 1). Except for the higher increase in 
aerobic capacity after SIT, we did not observe any other differences between the 
training modes in the measured parameters. 
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Lumbar vertebral region had the highest insulin-stimulated GU 
At baseline, both bone marrow insulin-stimulated glucose uptake (GU) (Figure 3A) and 
fasting free fatty acid uptake (FFAU) (Figure 3B) differed regarding the anatomical 
region in healthy subjects. Insulin-stimulated GU was significantly higher in lumbar 
vertebral bone marrow than in thoracic vertebral bone marrow (p <0.0001). Further, GU 
in femoral bone marrow was significantly lower than GU in lumbar vertebral or thoracic 
vertebral bone marrow (p <0.0001 for both). Fasting FFAU was higher in lumbar 
vertebral and thoracic vertebral than in femoral bone marrow (p <0.0001 for both). 
Similar regional differences in GU (Figure 3C) and FFAU (Figure 3D) were observed in 
the IR group with lumbar vertebral and femoral bone marrow. Thoracic vertebrae were 
not scanned in the IR group. 
Femoral bone marrow insulin-stimulated GU was impaired in IR subjects and improved 
after training 
At baseline, IR men had higher body mass, BMI and whole-body fat percentage, and 
their lipid and glucose profiles were impaired (all p <0.001) (Table 1). After the training 
intervention whole-body fat percentage decreased in the whole group and there were 
significant improvements in the lipid and glucose profiles (time all p <0.05) (Table 1). 
No difference was found in the training response between the groups. 
Insulin-stimulated GU in femoral bone marrow was impaired in IR men compared to 
healthy men (p <0.0001). Training improved GU similarly in both groups (Figure 4A). 
When femoral muscle GU was included as a covariate, the change in femoral bone 
marrow GU was no longer significant (data not shown). In lumbar vertebral bone 
marrow GU, no training induced changes were found in any comparisons (Figure 4B). 
Fasting FFAU in femoral bone marrow was impaired in IR men compared to healthy 
men (p = 0.016) and higher in women compared to men (p <0.001) (Figure 4C). This 
same phenomenon can be seen in lumbar vertebral bone marrow (p = 0.002 and p = 
0.023, respectively) (Figure 4D). Training decreased lumbar vertebral bone marrow 
FFAU similarly in healthy and IR men. However, no change was seen in comparisons 
between sexes or training modes. 
Femoral bone marrow GU correlated positively with whole-body insulin sensitivity (p 
<0.0001, r = 0.76, Figure 5A), lumbar bone marrow GU (p = 0.0004, r = 0.40) and 
negatively with BMI (p = 0.0008, r = -0.51Figure 5B). Both femoral and lumbar 
vertebral bone marrow GU correlated positively with aerobic capacity (femoral bone 
marrow p = 0.014, r = 0.39, Figure 5C, lumbar bone marrow p = 0.017, r = 0.38). 
Femoral bone marrow GU correlated positively with lumbar vertebral bone marrow GU 
(p = 0.0004, r = 0.40) but did not correlate with femoral (Figure 5D) or lumbar bone 
marrow FFAU. 
A multivariate regression analysis was conducted to study the predictors of femoral and 
lumbar bone marrow GU and FFAU using the key variables (glycemic status, weight, 
visceral adipose tissue volume, M-value, VO2peak, fasting glucose, osteocalcin, PINP, 
and bone marrow radiodensity). At baseline, the only statistically significant finding 
was the association between femoral bone marrow GU and M-value (R2 = 0.78, p 
<0.0001). Also, when we analyzed the change measured after exercise training, M-value 
still was the only statistically significant predictor for bone marrow GU (R2 = 0.59, p = 
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0.0004). None of the aforementioned key variables was a statistically significant 
predictor for bone marrow FFAU. 
Females had higher femoral and lumbar vertebral FFAU than males 
Females had higher body adiposity and level of circulating FFA’s than males at baseline 
(Table 2). Females had significantly higher femoral and lumbar vertebral bone marrow 
FFAU at baseline compared to males (Figure 4C-D). Interestingly, GU differed only for 
femoral bone marrow (p = 0.021, Figure 4A), with females having higher GU than 
males. However, training improved femoral bone marrow GU similarly in males and 
females.  
Radiodensity was higher in lumbar vertebral bone marrow than femoral bone marrow 
Radiodensity was higher in lumbar vertebral bone marrow (186.1 HU) than in femoral 
bone marrow (81.0 HU) in men (p <0.0001). Femoral bone marrow radiodensity was 
significantly lower in healthy men (74.5 HU) compared to IR men (87.5 HU, p = 
0.035). There was no difference in lumbar vertebral bone marrow radiodensity between 
healthy (191.6 HU) compared to IR subjects (180.5 HU, p = 0.35). There were no 
exercise induced changes in any of the groups. There was no significant difference 
between femoral or lumbar vertebral bone marrow radiodensity between IR men and 
women. Femoral bone marrow radiodensity correlated positively with weight (p = 
0.009, r = 0.29), BMI (p = 0.016, r = 0.27), fasting glucose (p = 0.023, r = 0.27), and 
fasting FFA (p = 0.025, r = 0.26) and correlated inversely with femoral bone marrow 
insulin stimulated GU (p = 0.035, r = -0.25). Lumbar vertebral bone marrow 
radiodensity correlated negatively with age (p = 0.031, r = -0.25), whole body fat 
percentage (p = 0.025, r = -0.25) and positively with VO2peak (p = 0.002, r = 0.34). 
Bone formation and remodeling markers were lower in the IR group 
At baseline, plasma osteocalcin concentration was lower in the IR than in the healthy 
group (p = 0.021, Table 1). Osteocalcin concentration correlated positively with whole-
body insulin sensitivity (p = 0.036, Figure 6A) and femoral bone marrow GU (p <0.003, 
Figure 6B). At baseline, PINP concentration was also lower in the IR than in the healthy 
group (p = 0.003, Table 1). PINP concentration correlated positively with whole-body 
insulin sensitivity (p = 0.027, Figure 6C), femoral bone marrow GU (p = 0.042, Figure 
6D), femoral bone marrow FFAU (p = 0.027, r = 0.37), and lumbar vertebral bone 
marrow FFAU (p = 0.026, r = 0.37), and correlated negatively with BMI (p = 0.033, r = 
-0.34) and blood triglycerides (p = 0.017, r = -0.37). However, exercise training had no 
effect on osteocalcin or PINP concentrations in either group (Table 1).  
DISCUSSION 
Here we show that there are differences in bone marrow metabolism depending on the 
anatomical location. Furthermore, bone marrow metabolism is impaired in insulin 
resistance and can be improved by exercise training. A two-week exercise training 
intervention increased bone marrow insulin-stimulated GU and decreased FFAU both in 
healthy and IR subjects. In IR subjects GU and FFAU were higher in females compared 
to males. Femoral bone marrow GU correlated positively with aerobic capacity and 
whole-body insulin sensitivity, and negatively with BMI. At baseline, osteocalcin and 
PINP levels were lower in the IR compared to healthy group and correlated with 
femoral bone marrow GU but were not affected by exercise training. 
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This study shows that insulin-stimulated GU in healthy humans differs according to 
anatomical location between thoracic vertebral, lumbar vertebral and femoral bone 
marrow, being highest in lumbar vertebral and lowest in femoral bone marrow. Fasting 
FFAU was also higher in vertebral than femoral bone marrow. The same phenomenon 
can be seen in the IR group in lumbar vertebral and femoral bone marrow. This may be 
explained by the differences in the composition of bone marrow and its role in 
hematopoiesis. In adult humans, the middle of the thigh is mostly adipose tissue, 
whereas the lumbar vertebral region still actively produces blood cells (1,2). The need 
for energy of hematopoietic tissue seems to be constant and not easily affected by 
environmental factors. However, femoral bone marrow appears to serve mainly as a fat 
depot, which has been shown to be insulin sensitive and react to exercise (11). When we 
further tested this hypothesis using CT-derived Hounsfield Units, the radiodensity was 
lower in femoral than lumbar vertebral bone marrow indicating higher fat content in 
femoral bone marrow. However, the bone marrow cavity includes adipose tissue, 
hematopoietic tissue and trabecular bone. Therefore, attenuation measurements of bone 
marrow cavity include multiple tissues and adipose tissue alone cannot be quantified. 
Nevertheless, the lower the HU, the higher the fat content (20) and in this context, we 
found that lumbar vertebral bone marrow radiodensity was in inverse relationship with 
age and whole-body fat percentage suggesting either an increase in adiposity or 
decrease in trabecular bone in lumbar BM cavity with aging and obesity. While, in 
femoral bone marrow cavity, where the influence of trabecular bone on bone marrow 
radiodensity is negligible, we found that lower femoral bone marrow radiodensity 
(high-fat content) in healthy compared to IR subjects. Further, we found that there exists 
a direct correlation of femoral BM radiodensity with body weight, BMI and an inverse 
relationship with insulin-stimulated femoral bone marrow GU. These findings are in 
line with Ermitici et al (24), where bone marrow fat content was measured using proton 
magnetic resonance spectroscopy and it was found that bone marrow fat content (%) 
was inversely related to the index of whole-body insulin resistance (HOMA-IR). It is 
possible that a higher fat content (more adipocytes) in bone marrow in healthy 
compared to IR subjects drive an increase in insulin stimulated GU since marrow 
adipocytes express insulin receptors (25) and previously we have also shown that 
insulin stimulates GU in bone marrow adipose tissue (26). In line with these findings 
femoral bone marrow GU, but not lumbar vertebral bone marrow, correlated negatively 
with BMI and positively with whole-body insulin sensitivity and IR subjects had lower 
insulin-stimulated bone marrow GU than healthy subjects at baseline. 
After the training we found an increase in femoral bone marrow insulin-stimulated GU 
but not in lumbar vertebral and thoracic vertebral bone marrow. In femoral bone 
marrow training increased GU in all groups. This finding agrees with our previous data 
from the same study protocol regarding the changes in skeletal muscle GU where we 
showed that GU improved only in the working muscles of the lower extremities and not 
in the upper body muscles (13). The training intervention consisted of bicycle ergometer 
training, which mainly strains the lower extremities explaining why GU improved only 
in femoral bone marrow. Our data agrees also with the findings of Huovinen and 
colleagues, who investigated the effects of whole-body resistance training on insulin-
stimulated bone marrow in elderly subjects and found that GU improved in femoral 
bone marrow but not in vertebral bone marrow after training (11). The difference in 
training response between vertebral and femoral bone marrow GU could also be 
explained by the amount of fat and the role of bone marrow. Hematopoietic tissue in 
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lumbar vertebral bone marrow may not be as easily affected by environmental factors 
compared to femoral bone marrow. 
Increase in the femoral bone marrow insulin-stimulated GU was no longer significant 
when we corrected the statistical analysis for muscle GU. This suggests that the increase 
in femoral bone marrow GU was not independent of the increase of GU in the 
surrounding muscle tissue. Indeed, in the multivariate analysis M-value showed to be 
the only statistically significant predictor of bone marrow insulin-stimulated GU. Our 
finding of increased femoral bone marrow GU may be also partially due to the PET 
methodology related spillover effect i.e. spilling of activity from the neighboring high 
activity tissues (muscles) to the less active areas (bone tissue). However, cortical bone 
between bone marrow cavity and muscle tissue should minimize the spillover effect 
(Figure 2). Our study suggests that bone marrow metabolism is improved by exercise 
training, however, further studies are needed to clarify the proportion of independent 
and muscle metabolism-induced changes. 
The comparisons between males and females were made within the IR group. We found 
that females had higher femoral bone marrow GU and higher femoral and lumbar 
vertebral FFAU than males at baseline. Females are known to be more insulin sensitive 
than men (27,28) and our results show this also at bone marrow level. At baseline, 
females had higher amount of circulating FFAs than males, which explains the 
difference in FFAU. Exercise training had no effect on the amount of circulating FFAs. 
Also, FFAU was not affected by exercise training in the IR group. The sample size for 
IR men and women was small so this response should be investigated further. 
Osteocalcin is a biochemical bone formation marker that is produced by osteoblasts. 
Osteocalcin concentrations were lower in IR than in healthy group at baseline in the 
present study which is in line with previous observations (29). It has also been shown 
before that circulating osteocalcin is negatively associated with IR, obesity, and diabetes 
(30). Our results support these findings, as osteocalcin correlated positively with whole-
body insulin sensitivity. In addition, to our knowledge, we show here for the first time 
that osteocalcin correlates positively with femoral bone marrow GU at baseline. PINP is 
synthesized by osteoblasts as part of Type I collagen formation and it has been 
recommended to be used as a reference analyte for bone turnover markers in 
observational and intervention studies (22). It has not been clearly established yet, how 
insulin resistance or diabetes affects PINP concentration (31). Similarly to osteocalcin, 
PINP concentration was lower in the IR group than in the healthy group. PINP also 
correlated positively with bone marrow GU and FFAU, whole-body insulin sensitivity, 
and negatively with BMI. However, there were no significant changes in either of the 
bone markers after the exercise training intervention. A two-week training intervention 
may be too short to induce significant changes in circulating osteocalcin or PINP 
concentrations. Also, training consisted of cycling which may not stimulate bone 
turnover as much as for example running or other high-impact exercise (32,33). 
This study is not without limitations. The number of study subjects was relatively small 
but typical for exercise training trials using demanding molecular imaging modalities. 
To avoid spillover effect from surrounding tissues, ROIs were drawn carefully in the 
bone marrow cavity on the PET images. Cortical bone acts as a barrier between bone 
marrow and surrounding tissue, so it is unlikely that spillover from muscles could have 
affected the bone marrow results. In order to stimulate bone marrow metabolism and 
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bone turnover optimally, running or other high-impact loading exercise would probably 
have been the best type of exercise. However, to standardize the SIT and MICT 
protocols in laboratory settings in sedentary subjects we preferred cycling in the current 
study. These findings show only the early training response, and the long-term effects of 
these training modes on bone marrow metabolism should be studied in further 
experiments.  
CONCLUSION 
Our data suggests that bone marrow metabolism differs regarding anatomical location 
and is impaired in insulin resistance. We show for the first time that short-term exercise 
training improves bone marrow glucose and free fatty acid metabolism similarly in 
healthy and insulin resistant men, similarly in men and women and regardless of 
training method. We also show that bone turnover markers osteocalcin and PINP are 
associated with insulin sensitivity.  
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FIGURES AND TABLES 
Figure 1. A) CONSORT flow diagram. The analyses were carried out using the 
intention-to-treat principle and included all the randomized participants. B) Study 
design. VO2peak test, aerobic capacity; OGTT, oral glucose tolerance test; 18F-FTHA, 
14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid; 18F-FDG, 2-[18F]fluoro-2-deoxy-D-
glucose; MRI, magnetic resonance imaging; SIT, sprint-interval training; MICT, 
moderate-intensity continuous training. 
Figure 2. An example of the shape and positioning of the region of interest (ROI) from 
which time activity curves were extracted. Sagittal PET/CT image of lumbar vertebral 
(A) and femoral (B) regions. Transaxial PET/CT image of lumbar vertebral (C) and 
femoral (D) regions. CT scans were used as anatomical reference. 
Figure 3. Substrate uptake differs according to anatomic region. Statistical analyses 
were done only between femoral, thoracic vertebral and lumbar vertebral bone marrow 
results. *p<0.0001. Data is model based means with 95% confidence intervals (CI). IR, 
insulin resistant; QF, quadratus femoris muscle; GU, glucose uptake; FFAU, free fatty 
acid uptake. 
Figure 4. A-B) Bone marrow insulin-stimulated GU is impaired in IR group and 
improves after training. C-D) Bone marrow fasting FFAU is higher in healthy subjects 
and IR women but improves after training in lumbar vertebrae. # difference at baseline, 
p<0.05. * difference between pre and post measurements, p<0.05. Data is model based 
means with 95% confidence intervals (CI). IR, insulin resistant; SIT, sprint-interval 
training; MICT, moderate-intensity continuous training; GU, glucose uptake; FFAU, 
free fatty acid uptake. 
Figure 5. Baseline correlations. Healthy subjects have been marked with a circle and IR 
subjects with a square. Femoral bone marrow GU correlates positively with whole body 
insulin sensitivity, aerobic capacity, and negatively with BMI. There was no correlation 
between femoral bone marrow GU and FFAU. &Logarithmic transformation was 
performed to fulfill normal distribution assumption. IR, insulin resistant; M-value, 
whole-body insulin sensitivity; BMI, body mass index; VO2peak, aerobic capacity, GU, 
glucose uptake; FFAU, free fatty acid uptake. 
Figure 6. Bone turnover marker correlations at baseline. Healthy subjects have been 
marked with a circle and IR subjects with a square. A-B) Osteocalcin correlates 
positively with whole-body insulin sensitivity and femoral bone marrow GU. C-D) Also 
PINP correlates positively with whole-body insulin sensitivity and femoral bone 
marrow GU. &Logarithmic transformation was performed to fulfill normal distribution 
assumption. IR, insulin resistant; M-value, whole-body insulin sensitivity; GU, glucose 











































Table 1: Subject characteristics between healthy and IR men before and after exercise intervention. 
Parameter Healthy men IR men Baseline Time Time*IR 
 Pre Post Pre Post    
Anthropometrics 
       
Weight (kg) 83.6 [79.7;87.5] 83.3 [79.4;87.2] 96.3 [91.2;101.3] 96.2 [91.0;101.3] <0.001 0.22 0.80 
BMI (kg/m2) 26.1 [25.1;27.1] 26.0 [25.0;27.0] 30.4 [29.1;31.8] 30.4 [29.0;31.7] <0.001 0.17 0.70 
Whole body fat& (%) 22.6 [20.9;24.3] 21.7 [20.0;23.3] 28.8 [26.5;31.2] 28.1 [25.7;30.4] <0.001 <0.001 0.78 
Visceral fat† (kg) 2.5 [2.0;3.2] 2.4 [1.9;3.08] 4.3 [5.4;3.4] 4.1 [3.1;5.1] 0.002 0.002 0.48 
VO2peak (mL/kg/min) 34.2 [32.7;35.7] 35.7 [34.2;37.2] 29.3 [27.2;31.4] 30.0 [27.9;32.1] <0.001 0.003 0.23 
Glucose profile 
       
Glucosefasting& 
(mmol/L) 5.5 [5.4;5.7] 5.7 [5.5;6.0] 7.2 [6.9;7.6] 7.1 [6.8;7.5] <0.001 0.26 0.086 
M-value& 
(µmol/min/kg) 35.3 [30.0;40.6] 38.7 [33.3;44.1] 17.5 [10.3;24.8] 21.6 [14.2;29.0] <0.001 <0.001 0.11 
HbA1c (mmol/mol) 36.9 [35.2;38.6] 34.8 [33.0;36.5] 39.6 [37.3;41.8] 37.5 [35.2;39.9] 0.071 <0.001 0.87 
HbA1c (%) 5.5 [5.4;5.7] 5.3 [5.2;5.5] 5.8 [5.6;6.0] 5.6 [5.4;5.8] 0.080 <0.001 0.90 
Lipid profile 
       
FFAfasting (mmol/L) 0.70 [0.62;0.77] 0.62 [0.54;0.69] 0.69 [0.60;0.78] 0.68 [0.59;0.78] 0.86 0.04 0.11 
Cholesterol (mmol/L) 4.9 [4.6;5.3] 4.4 [4.1;4.7] 4.7 [4.3;5.2] 4.3 [3.9;4.8] 0.44 <0.001 0.52 
HDL& (mmol/L) 1.4 [1.3;1.5] 1.3 [1.2;1.4] 1.2 [1.1;1.4] 1.1 [1.0;1.2] 0.08 <0.001 0.66 
28 
 
LDL (mmol/L) 3.1 [2.9;3.4] 2.8 [2.5;3.1] 2.7 [2.3;3.1] 2.6 [2.2;3.0] 0.09 <0.001 0.16 
Triglycerides& 
(mmol/L) 0.94 [0.81;1.11] 0.83 [0.70;0.98] 1.70 [1.38;2.10] 1.50 [1.19;1.90] <0.001 0.08 0.96 
Bone markers 
       
Osteocalcin (ng/ml) 7.97 [7.28;8.65] 7.64 [6.92;8.36] 6.64 [5.72;7.55] 6.76 [5.78;7.74] 0.02 0.66 0.32 
PINP& 
51.3 [45.7;57.4] 48.1 [42.6;54.3] 38.0 [32.4;44.5] 38.9 [32.9;46.0] 0.003 0.68 0.37 
 
All values are model based means [95% confidence intervals]. Log transformation & or square root transformation † was performed to fulfill normal 
distribution assumption. P-value for Baseline indicates the differences between healthy and IR men. P-value for Time indicates the change between pre 
and post measurements in the whole study group. P-value for Time*IR interaction indicates if the change in the parameter was different between 
healthy and IR men. IR, insulin resistant; BMI, body mass index; VO2peak, aerobic capacity; M-value, whole-body insulin sensitivity; HbA1c, 





Table 2: Subject characteristics between IR men and women before and after exercise intervention. 
Parameter IR men IR women Baseline Time Time*Sex 
 Pre Post Pre Post    
Anthropometrics        
Weight (kg) 
96.5 [90.3;102.7] 96.3 [90.1;102.5] 84.3 [76.4;92.2] 83.3 [75.4;91.2] 0.02 0.03 0.13 
BMI (kg/m2) 
30.5 [29.0;32.0] 30.4 [28.9;31.9] 30.4 [28.5;32.3] 30.0 [28.1;32.0] 0.97 0.03 0.10 
Whole body fat& (%) 
28.5 [26.4;30.8] 27.7 [25.6;29.9] 40.7 [36.8;45.1] 39.4 [35.6;43.6] <.0001 0.01 0.81 
Visceral fat& (kg) 
4.3 [3.6, 5.2] 4.1 [3.4, 5.0] 2.4 [1.7, 3.2] 2.3 [1.6, 3.1] <.001 0.01 0.83 
VO2peak (mL/kg/min) 
29.3 [27.4;31.2] 29.9 [28.0;31.9] 23.7 [21.3;26.2] 24.3 [21.7;26.8] <.001 0.15 0.95 
Glucose profile 
       
Glucosefasting& 
(mmol/L) 
6.6 [6.2;7.1] 6.6 [6.2;7.1] 6.6 [6.1;7.2] 6.4 [5.8;6.9] 0.95 0.27 0.21 
M-value 
(µmol/min/kg) 
17.5 [11.6;23.5] 21.8 [15.6;27.9] 19.9 [12.7;27.0] 22.2 [14.6;29.9] 0.66 0.07 0.59 
HBA1c (mmol/mol) 
39.6 [37.0;42.1] 37.6 [35.0;40.2] 39.5 [36.3;42.8] 37.7 [34.4;41.0] 0.99 <.01 0.88 
HbA1c (%) 5.8 [5.5;6.0] 5.6 [5.4;5.8] 5.8 [5.5;6.1] 5.6 [5.3;5.9] 0.99 0.001 0.8 
Lipid profile 
       
FFAfasting (mmol/L) 
0.69 [0.61;0.77] 0.68 [0.60;0.77] 0.96 [0.85;1.07] 0.91 [0.79;1.04] <.0001 0.38 0.56 
Cholesterol (mmol/L) 




1.2 [1.1;1.4] 1.1 [0.9;1.2] 1.5 [1.2;1.7] 1.4 [1.2;1.7] 0.052 0.02 0.12 
LDL (mmol/L) 
2.7 [2.3;3.1] 2.6 [2.2;3.0] 2.9 [2.4;3.5] 2.4 [1.9;3.0] 0.43 0.01 0.14 
Triglycerides& 
(mmol/L) 
1.7 [1.3;2.2] 1.5 [1.1;2.0] 1.2 [0.9;1.7] 1.2 [0.9;1.7] 0.12 0.55 0.69 
Bone markers 
       
Osteocalcin (ng/ml)& 
6.48 [5.43;7.73] 6.59 [5.51;7.88] 6.12 [4.88;7.67] 6.22 [4.95;7.82] 0.89 0.48 0.99 
PINP& 
37.7 [30.6;46.6] 38.6 [31.3;47.8] 39.1 [30.1;50.8] 37.4 [28.6;48.8] 0.55 0.73 0.27 
 
All values are model based means [95% confidence intervals]. & Log transformation was performed to fulfill normal distribution assumption. P-value 
for Baseline indicates baseline differences between IR men and women. P-value for Time indicates the change between pre and post measurements in 
the whole study group. P-value for Time*Sex interaction indicates if the change in the parameter was different between men and women in the IR 
group. IR, insulin resistant; BMI, body mass index; VO2peak, aerobic capacity; M-value, whole-body insulin sensitivity; HbA1c, glycosylated 
hemoglobin; FFA, free fatty acids; HDL, high density lipoprotein; LDL, low density lipoprotein; PINP, procollagen type 1 N-terminal propeptide. 
 
 
